Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.97B.
ENTERPRISE VALUE (EV)
$1.97B
HeartSciences Inc.
Market Cap
$8.18M
Enterprise Value (EV)
$1.97B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| HeartSciences Inc. (HSCS) | $8.18M | $1.97B |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.13M | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $8.01M | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.41M | $19.50M |
| GT Biopharma, Inc. (GTBP)vs › | $8.00M | $3.04M |
| Traws Pharma, Inc. (TRAW)vs › | $7.93M | $4.79M |
| DataMEDS AI, Inc. (MEDS)vs › | $8.53M | $38.69M |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.84M | $6.53M |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.59M | N/A |
| Skye Bioscience, Inc. (SKYE)vs › | $7.31M | N/A |
Market Cap
$8.18M
Total Debt
$3.62B
Cash
$1.66B
Enterprise Value
$1.97B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
